Thrombocytopenia in Pregnancy: Clinical Challenges, Maternal-Fetal Risks, and Management Strategies

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Perinatology

Background:

• Thrombocytopenia affects up to 10% of pregnancies, being the second most common hematologic disorder.
• Common causes include immune-mediated thrombocytopenia, HELLP syndrome, preeclampsia, and benign gestational thrombocytopenia.

Purpose of the Study:

• To review the diagnostic evaluation, pathophysiology, and differential diagnosis of thrombocytopenia in pregnancy.
• To outline maternal and fetal complications associated with pregnancy-related thrombocytopenia.
• To discuss current evidence-based management strategies for thrombocytopenia during pregnancy.

Main Methods:

• Narrative review of existing literature.
• Focus on diagnostic approaches and differential diagnosis.
• Synthesis of information on maternal-fetal complications and management.

Main Results:

• Accurate diagnosis is critical as the etiology influences maternal health, pregnancy management, and neonatal outcomes.
• Potential complications include maternal bleeding, preterm birth, and neonatal thrombocytopenia.
• Management strategies encompass immunomodulatory therapies, platelet transfusions, and close clinical monitoring.

Conclusions:

• A comprehensive and clinically guided approach to thrombocytopenia in pregnancy is essential.
• Personalized perinatal care is key to maximizing maternal and fetal well-being.
• Effective management requires a thorough understanding of underlying causes and potential risks.